Exjade - 0078-0469-15 - (deferasirox)

Alphabetical Index


Drug Information of Exjade

Product NDC: 0078-0469
Proprietary Name: Exjade
Non Proprietary Name: deferasirox
Active Ingredient(s): 250    mg/1 & nbsp;   deferasirox
Administration Route(s): ORAL
Dosage Form(s): TABLET, FOR SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of Exjade

Product NDC: 0078-0469
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021882
Marketing Category: NDA
Start Marketing Date: 20051130

Package Information of Exjade

Package NDC: 0078-0469-15
Package Description: 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15)

NDC Information of Exjade

NDC Code 0078-0469-15
Proprietary Name Exjade
Package Description 30 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-0469-15)
Product NDC 0078-0469
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name deferasirox
Dosage Form Name TABLET, FOR SUSPENSION
Route Name ORAL
Start Marketing Date 20051130
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name DEFERASIROX
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Iron Chelating Activity [MoA],Iron Chelator [EPC]

Complete Information of Exjade


General Information